Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALFUZOSIN for Benign prostatic hyperplasia: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 849 adverse event reports in the FDA FAERS database where ALFUZOSIN was used for Benign prostatic hyperplasia.

Most Reported Side Effects for ALFUZOSIN

Side Effect Reports % Deaths Hosp.
Fall 174 6.8% 8 148
Hypotension 164 6.4% 4 110
Drug ineffective 150 5.9% 0 55
Acute kidney injury 113 4.4% 12 93
Dizziness 113 4.4% 0 32
Malaise 105 4.1% 0 82
Off label use 91 3.6% 4 62
Dyspnoea 82 3.2% 0 45
Neutropenia 82 3.2% 14 40
Syncope 81 3.2% 1 45
Thrombocytopenia 80 3.1% 5 51
Pituitary tumour benign 77 3.0% 0 0
Agranulocytosis 76 3.0% 0 61
Growth hormone deficiency 76 3.0% 0 0
Loss of consciousness 67 2.6% 1 35

Other Indications for ALFUZOSIN

Product used for unknown indication (801) Urinary retention (97) Prostatomegaly (86) Prostatic disorder (44) Micturition disorder (37) Dysuria (36) Prostate cancer (32) Prostatic adenoma (30) Urinary tract disorder (28) Hypertension (24)

Other Drugs Used for Benign prostatic hyperplasia

TAMSULOSIN (3,156) TADALAFIL (1,154) FINASTERIDE (1,104) DUTASTERIDE (1,004) SILODOSIN (628) DUTASTERIDE\TAMSULOSIN (313) DOXAZOSIN (219) HERBALS\SAW PALMETTO (181) MIRABEGRON (93) TERAZOSIN (61)

Related Pages

ALFUZOSIN Full Profile All Benign prostatic hyperplasia Drugs ALFUZOSIN Demographics ALFUZOSIN Timeline